BMY vs FMAO · P/E 17, rev $24.46B vs P/E 11, rev $88.9M
Bristol-Myers Squibb Company (BMY) versus Farmers & Merchants Bancorp Inc (FMAO) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Farmers & Merchants Bancorp Inc (FMAO) is a banks - regional company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported FMAO revenue for 2026-06-30 was $88.9M. Net income was $21.4M. FMAO currently screens at market cap $386.7M and trailing P/E 10.7.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. FMAO currently screens at market cap $386.7M and trailing P/E 10.7.
Not investment advice. Open the BMY and FMAO stock pages for the full models.
Not investment advice.